Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting · NCT07039110 · Observational (researchers observe without assigning treatment) · Lead sponsor: AbbVie
View the official record on ClinicalTrials.gov →What this trial is about
Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. This study will assess the change in quality of life of risankizumab treatment in adult participants with moderate to severe plaque psoriasis real-world clinical practice. Risankizumab is an approved drug for treating participants with Psoriasis. Approximately 700 participants who are prescribed risankizumab by their physician in accordance with local label will be enrolled in approximately 70 sites worldwide. Participants will receive risankizumab as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 2.5 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Participants with a Confirmed diagnosis of moderate-to-severe plaque psoriasis with or without joint involvement according to the treating physician's clinical judgment, prior to time of enrollment.
- Treatment with risankizumab is indicated per summary of product characteristics (SmPC) or local label and local prescribing/treatment guidelines.
- Decision to treat with risankizumab is made prior to and independently of study participation.
Exclusion criteria
- History of a sleep disorder diagnosis which the patient is currently being treated for.
- Current or recent (within the last 30 days) participation in an interventional clinical trial or an observational study.
- Currently receiving other biologic treatments and/or small molecules including Janus kinase (JAK) inhibitors, tyrosine kinase 2 (TYK2) inhibitors, and phosphodiesterase 4 (PDE4) inhibitors for any reason.
Where it is running
60 locations listed.
- Fukuoka University Hospital /ID# 278600 - Fukuoka, Japan
- Ospedale San Martino /ID# 278984 - Genova, Italy
- Universitaetsklinikum Hamburg-Eppendorf /ID# 277164 - Hamburg, Germany
- Cutaneum /ID# 277294 - Hamburg, Germany
- Private Practice - Dr. Mario Pawlak /ID# 277465 - Heilbad Heiligenstadt, Germany
- Hautarztpraxis Dr. Med. Ulrike Wiemers / Dr. Med. Franca Wiemers /ID# 277821 - Leipzig, Germany
- Hospital General Universitario Morales Meseguer /ID# 283339 - Murcia, Spain
- Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 278434 - Osaka, Japan
- Complejo Hospitalario Universitario de Pontevedra /ID# 278085 - Pontevedra, Spain
- Fakultni nemocnice Kralovske Vinohrady /ID# 275800 - Prague, Czechia
- Hautarztpraxis Schwelm /ID# 277464 - Schwelm, Germany
- Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 276488 - Thessaloniki, Greece
- Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 276489 - Thessaloniki, Greece
- Papageorgiou General Hospital /ID# 276487 - Thessaloniki, Greece
- Tokyo Yamate Medical Center /ID# 278960 - Tokyo, Japan
- Teikyo University Hospital /ID# 278228 - Tokyo, Japan
- Nihon University Itabashi Hospital /ID# 279916 - Tokyo, Japan
- Hospital Universitario De Toledo /ID# 277896 - Toledo, Spain
- Nemocnice Ceske Budejovice /ID# 275541 - České Budějovice, Czechia
- Dermatology Research Institute - Blackfoot Trail /ID# 276722 - Calgary, Alberta, Canada
- Rejuvenation Dermatology - Edmonton Downtown /ID# 276688 - Edmonton, Alberta, Canada
- Hospital Regional Universitario de Malaga /ID# 277220 - Málaga, Andalusia, Spain
- General Hospital Andreas Syggros /ID# 276826 - Athens, Attica, Greece
- General Hospital Andreas Syggros /ID# 279246 - Athens, Attica, Greece
- University General Hospital Attikon /ID# 278389 - Chaïdári, Attica, Greece
- Tzaneio Prefecture General Hospital of Piraeus /ID# 276532 - Piraeus, Attica, Greece
- Asklipieio General Hospital of Voula /ID# 278235 - Voula, Attica, Greece
- Dr. med. Moritz Huber und Dr. med. Martin Heister /ID# 277627 - Friedrichshafen, Baden-Wurttemberg, Germany
- Dermakulm /Id# 277864 - Kulmbach, Bavaria, Germany
- Dermazent /Id# 280327 - Munich, Bavaria, Germany
- Chu de Dijon /ID# 279900 - Dijon, Bourgogne-Franche-Comté, France
- Hautaerzte am Nauener Tor /ID# 284579 - Potsdam, Brandenburg, Germany
- Fakultni Nemocnice U Sv. Anny V Brne /ID# 275799 - Brno, Brno-mesto, Czechia
- Fakultni nemocnice Bulovka /ID# 275540 - Prague, Central Bohemia, Czechia
- Centre Hospitalier de Niort Georges Renon /ID# 279604 - Niort, Deux-Sevres, France
- Hopitaux Drome Nord - Romans /ID# 278109 - Romans-sur-Isère, Drome, France
- Gunma University Hospital /ID# 278497 - Maebashi, Gunma, Japan
- Asahikawa Medical University Hospital /ID# 278981 - Asahikawa-shi, Hokkaido, Japan
- Hokkaido University Hospital /ID# 278260 - Sapporo, Hokkaido, Japan
- Hosui General Medical Clinic /ID# 279520 - Sapporo, Hokkaido, Japan
- Kagoshima University Hospital /ID# 278514 - Kagoshima, Kagoshima-ken, Japan
- Tokai University Hospital /ID# 278294 - Isehara, Kanagawa, Japan
- Yokohama City University Hospital /ID# 278257 - Yokohama, Kanagawa, Japan
- University Hospital Kyoto Prefectural University of Medicine /ID# 278962 - Kyoto, Kyoto, Japan
- ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 277341 - L’Aquila, L Aquila, Italy
- Hospital Universitario de Leon /ID# 277895 - León, Leon, Spain
- Winnipeg Clinic /ID# 276751 - Winnipeg, Manitoba, Canada
- Wiseman Dermatology Research /ID# 276847 - Winnipeg, Manitoba, Canada
- IRCCS Ospedale San Raffaele /ID# 277342 - Milan, Milano, Italy
- Hospital General Universitario Santa Maria Del Rosell /ID# 277894 - Cartagena, Murcia, Spain
- Hospital Clinico Universitario Virgen de la Arrixaca /ID# 283338 - El Palmar, Murcia, Spain
- Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 277713 - Naples, Napoli, Italy
- Klinikum Dortmund Klinikzentrum Mitte /ID# 284856 - Dortmund, North Rhine-Westphalia, Germany
- Dr. Rima Mohty /ID# 279951 - Beauvais, Oise, France
- Kawasaki Medical School Hospital /ID# 278259 - Kurashiki, Okayama-ken, Japan
- University of the Ryukyus Hospital /ID# 278256 - Ginowan-shi, Okinawa, Japan
- Cca Medical Research /ID# 276944 - Ajax, Ontario, Canada
- Quinte dermatology /ID# 277497 - Belleville, Ontario, Canada
- Dermatrials Research /ID# 276714 - Hamilton, Ontario, Canada
- Lovegrove Dermatology /ID# 276797 - London, Ontario, Canada
Showing 60 of 83 listed sites. See the official record for the complete list.
Read the full protocol, contacts and eligibility on ClinicalTrials.gov →